Stimulation of adenosine receptor enhances α1 -adrenergic receptor-mediated activation of phospholipase C and Ca2+ mobilization in a pertussis toxin-sensitive manner in FRTL-5 thyroid cells  by Okajima, Fumikazu et al.
Volume 248, number 1,2, 145-149 FEB 07116 May 1989 
Stimulation of adenosine receptor enhances a, -adrenergic receptor- 
mediated activation of phospholipase C and Ca2+ mobilization in 
a pertussis toxin-sensitive manner in FRTL-5 thyroid cells 
Fumikazu Okajima, Koichi Sato, Kimie Sho and Yoichi Kondo 
Department of Physical Biochemistry. institute of Endocrinology, Gunma University. Maebashi 371, Japan 
Received 8March 1989 
Norepinephrine (NE) stimulated FRTL-5 thyroid cells via an a,-adrenergic receptor, resulting in cytosolic Caz+ ([Ca2’li) 
mobilization and activation of phospholipase C. Adenosine and its receptor agonist, phenylisopropyladenosine (PIA), 
although not exerting a direct effect, markedly enhanced the NE-induced changes. Basal NE action was not totally abol- 
ished whereas the permissive action of adenosine and PIA was completely abolished by pretreatment of the cells with 
islet-activating protein (IAP), pertussis toxin. The decrease in CAMP level induced by adenosine or PIA is not the cause 
of their permissive lfect, since this effect was not reversed by the addition of CAMP-increasing agents. We conclude that 
an IAP substrate GTP-binding protein(s) plays a novel role in forming a stimulatory coupling between an adenosine 
receptor and an a,-adrenergic receptor-coupled phospholipase C system. 
GTP-binding protein; Islet-activating protein; Phospholipase C; Adrenergic receptor, a,-; Adenosine receptor; (FRTL-5 cell) 
1. INTRODUCTION 
GTP-binding proteins (G-proteins) have recently 
been suggested to be involved in receptor-mediated 
activation of phosphohpase C [1,2]. The 
postulated G-protein is referred to as GP [2], being 
distinct from G, as stimulatory and Gi as inhibitory 
G-proteins for adenylate cyclase [3]. Islet- 
activating protein (IAP), pertussis toxin, ADP- 
ribosylates Gi and Gr-like proteins resulting in the 
loss of their regulatory functions for adenylate 
cyclase [l-3]. The toxin, although not in all cases, 
also inhibits receptor-mediated phospholipase C 
activation [1,2], suggesting the presence of at least 
two species of Gp, i.e. IAP-sensitive and insensitive 
forms [1,2]. 
We recently found that extracellular ATP, via a 
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Pz-purinergic receptor, activated phospholipase C 
and Ca2+ mobilization in FRTL-5 thyroid cells 
[4,5]. This Pz-receptor-mediated enzyme activation 
was inhibited by IAP, however inhibition was par- 
tial even though an approx. 41 kDa IAP substrate 
G-protein was completely ADP-ribosylated. On 
the other hand, phospholipase C activation by 
err-adrenergic agonists was hardly influenced by 
the toxin treatment in the same cells [6]. To gain 
further insight into the role of the IAP substrate in 
the regulation of phospholipase C, we investigated 
here the cooperation between norepinephrine, an 
cur-adrenergic agonist, and adenosine receptor 
agonists which inhibit adenylate cyclase in an IAP- 
sensitive manner, but do not affect phospholipase 
C [7]. The adenosine receptor agonists remarkably 
enhanced the IAP-insensitive action of 
norepinephrine on FRTL-5 cells. Only the per- 
missive actions of adenosine receptor agonists were 
totally sensitive to IAP, suggesting the involve- 
ment of IAP-substrate G-protein(s) with a novel 
role. 
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2. MATERIALS AND METHODS (A) Cmtrol 
2.1. Materials 
Norepinephrine, prazosin, yohimbine, propranolol, for- 
skolin, @-(L-2-phenylisopropyl)adenosine (PIA), adenosine 
and theophylline were purchased from Sigma; myo-[2-‘HIin- 
ositol (15.6 Ci/mmol) was from New England Nuclear. IAP 
was generously provided by Dr Michio Ui of Tokyo University 
(Tokyo, Japan) and 4-(3-butoxy-4-methyoxybenzyl)-2-imida- 
zolidione (RO 20-1724) by Nippon Roche Research Center 
(Kamakura, Japan). Reagents for CAMP radioimmunoassay 
were also a gift from Yamasa Shoyu Co. (Chosi, Japan). The 
sources of all other reagents used were those described in [4,5]. 
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2.2. Cell culture 
FRTL-5 cells, a cell line derived from normal rat thyroid [S], 
was provided by Interthyr Research Foundation (Baltimore, 
MD). Cells were grown as in [5]. After cells had reached 
6O-70% confluence in 12-well plates (for measuring CAMP 
content and [3H]inositol phosphate production) or IO-cm 
culture dishes (for measuring cytosolic Ca2+ ([Ca”]i)), the 
culture medium was changed to Ham’s 10 medium containing 
5% calf serum with a six-hormone mixture of thyrotropin, in- 
sulin, hydrocortisone, transferrin, somatostatin and Gly-His- 
Lys acetate as described [5] and maintained for a further 2 days. 
Where indicated, the medium was supplemented with 10 ng/ml 
IAP, [‘Hlinositol (3 &i in 1 ml medium) or both as shown in 
141. 
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[Ca*‘]i was estimated from the change in fluorescence of fura 
2-loaded cells in the presence of 2 mM extracellular Ca*+ as 
described [4,5]. 
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2.4. Measurement of tH]inositol phosphate production and 
CAMP content 
After preincubation at 37°C for 10 min in Hepes-buffered 
medium (composition as described in [4]), [“Hlinositol-loaded 
cells were incubated first for 10 min with 10 mM LiCl, and fur- 
ther for the indicated times with agents to be tested. Reactions 
were terminated by aspirating off the medium and addition of 
1 ml of 0.1 N HCl, followed by the cells being frozen. The 
supernatant (acid extract) of the thawed cells was used for 
separation of [‘Hlinositol phosphates as described [4]. Data 
were normalized to lo5 dpm of the radioactivity (not extracted 
with acid) remaining in the control (unstimulated) cells, which 
corresponded to the total inositol lipid. In the experiments 
shown in fig.4, part of the acid extract (0.1 ml) was also used 
for measurement of CAMP by radioimmunoassay as in [9]. 
Fig.1. Effects of PIA and adrenergic antagonists on NE- 
induced increase in [Ca*+]t. FRTL-5 cells treated with (B) and 
without (A) IAP were used in suspension and loaded with fura 
2 as described in section 2. In (g) and (j), the loaded cells were 
washed twice with Ca*+-free Hepes-buffered medium 
containing 0.1 mM EGTA, and the change in fluorescence 
intensity was monitored in the same Ca*+-free medium. At the 
times indicated by arrows, norepinephrine (N) (1 PM), prazosin 
(Praz) (10 nM), yohimbine (Yoh) (100 nM), propranolol (Prop) 
(10pM) or PIA (P) (100 nM) was added to the incubation 
medium. Data are representative of 3-10 separate xperiments. 
3. RESULTS AND DISCUSSION 
Fig.lA shows time courses of [Ca’+]i in the 
presence and absence of norepinephrine (NE) as 
well as PIA, an adenosine derivative. [Ca’+]i was 
increased about 1.5fold by addition of NE (a). 
This NE-induced increase was inhibited by 
prazosin, an cui-adrenergic antagonist (b), but not 
by yohimbine, an cuz-antagonist (c) and pro- 
pranolol, a &antagonist (d), suggesting 
al-receptor-mediated Ca2+ mobilization. When 
PIA was added 1 min after NE addition, [Ca’+]i 
was further increased (e). Although addition of 
PIA induced no change in [Ca’+]i, the subsequent 
addition of NE caused a marked increase in [Ca2+]i 
(f) which reached the same level as that obtained 
when PIA was added after NE. Removal of ex- 
tracellular Ca2+ (g) resulted in essentially no 
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change in the action of either NE or PIA, except 
for a decrease in both basal and stimulated level of 
[Ca’+]i. This suggests that at least part of the Ca2+ 
was mobilized from an intracellular pool in 
response to NE and PIA. When cells were treated 
with IAP, the PIA effect was completely lost 
regardless of extracellular Ca2+ (fig. lB,h-j), 
whereas the basal response to NE was not ap- 
preciably affected by the toxin treatment. 
As shown in fig.2A, theophylline, an adenosine 
receptor antagonist, shifted the PIA dose-response 
curve to the right and increased the EC50 from 
about 50 nM to 1 PM, without substantial change 
in the basal Ca2+ response to NE. Such a com- 
petitive nature of the theophylline effect suggests 
that the PIA response is mediated by an adenosine 
receptor. The action of adenosine was similar to 
that of PIA, as also shown in fig.2A. The potency 
of adenosine was one order lower than that of 
PIA. The action of adenosine was also completely 
abolished by IAP pretreatment (fig.2B). 
The NE-induced [Ca’+]i increase has been 
shown to be associated with phospholipase C ac- 
tivation [6,10]. We therefore examined the effect 
of PIA on the NE-induced activation of this en- 
zyme by determining the increase in inositol 
phosphates, as demonstrated in fig.3. As expected, 
PIA, which had no effect by itself, caused a signifi- 
cant enhancement in NE action. IAP pretreatment 
of cells again completely inhibited the permissive 
action of PIA, with no influence on the basal NE 
action (fig.3B). 
When we consider the mechanism of this novel 
permissive ffect of adenosine receptor agonists, it 
should be noted that PIA [7] and NE [l l] have 
been shown to inhibit CAMP accumulation in 
FRTL-5 cells. These facts provide support for the 
possibility that the decrease in CAMP content may 
be related to the mechanism of permissive action. 
This led us to investigate whether the increase in 
CAMP level induced by forskolin, an activator of 
adenylate cyclase, and Ro 20-1724, a phospho- 
diesterase inhibitor without antagonistic action on 
adenosine receptors, would reverse the permissive 
action of PIA (fig.4). In accordance with the 
previous study [7], PIA inhibited CAMP accumula- 
tion either stimulated by Ro 20-1724 plus forskolin 
or unstimulated, and this PIA action completely 
disappeared on IAP pretreatment (fig.4B), sug- 
gesting G-mediated inhibition. However, when 
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Fig.2. Dose-dependent enhancement of NE (1 pM)-induced 
increase in [Ca’+]r by PIA in the presence (0) or absence (0) of 
theophylline (Theoph), and by adenosine (Ado) (A) in control 
cells (A) and IAP-treated cells (B). Theophylline (100 ,uM) and 
PIA (or adenosine) were added 1 min before and at the same 
time as NE addition, respectively. The difference between 
maximal [Ca*‘]i estimated from the peak height at around 10 s 
after NE addition and basal [Ca’+]r just before NE addition is 
shown. PIA, adenosine or theophylline alone had no significant 
effect on [Ca*+]i at the concentrations employed. Data are 
means of two separate experiments. 
PIA was added to Ro 20-1724 plus forskolin- 
stimulated cells, the CAMP level was still much 
higher than that of unstimulated cells regardless of 
the presence of NE. Under such conditions of high 
CAMP levels, PIA definitely enhanced the NE- 
induced production of inositol phosphates, 
although the rates of NE and PIA actions slightly 
decreased (fig.4C). In addition, NE inhibited Ro 
20-1724 plus forskolin-induced CAMP accumula- 
tion in an IAP-insensitive manner (fig.4A,B), 
probably by activating Ro 20-1724-insensitive 
Ca2+-dependent phosphodiesterase [ 11,121. This 
Gi-independent decrease in CAMP level also was 
not accompanied by permissive action in IAP- 
treated cells (fig.4A,B). These results suggest hat 
a change in CAMP content is not responsible for 
the permissive action of PIA and its reversal by 
IAP. 
The present findings indicate the involvement of 
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Fig.3. Effect of PIA on NE-induced inositol phosphate 
production. Cells were treated with (B) or without (A) IAP in 
the presence of [3H]inositol as described in section 2. Cells were 
incubated for 30 min with the indicated concentrations of NE 
in the presence (0) or absence (0) of 1 gM PIA. Data are 
means + SE of three determinations for a representative 
experiment. Two other experiments gave similar results. 
adenosine receptors and an IAP substrate G- 
protein(s) in the permissive ffect of adenosine and 
PIA on norepinephrine-induced phospholipase C 
activation and Ca2+ mobilization. Since either 
adenosine or PIA alone cannot exert these 
metabolic effects, the IAP substrate G-protein 
may not directly link the adenosine receptor to the 
phospholipase C-Ca2+ system. This occurred only 
when the system was activated by an agonist- 
coupled receptor in an IAP-insensitive manner. 
We recently observed similar permissive ffects of 
adenosine receptor agonists on Pz-purinergic 
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Fig.4. Effect of PIA on CAMP accumulation (A,B) and NE- 
induced inositol phosphate production (C,D). Cells were 
treated with (B,D) or without (A,C) IAP in the presence of 
[‘Hlinositol as described in section 2. The cells were incubated 
for 10 min with (stippled bars) or without (open bars) PIA 
(1 PM) in the presence or absence of 1 PM norepinephrine (NE). 
The incubation medium, where indicated, was supplemented 
with Ro 20-1724 (2OOpM) plus forskolin (10pM). Data are 
means + SE of three separate xperiments. 
agonist (such as GTP and bromo-ATP)-induced 
phospholipase C activation and Ca2+ mobilization 
also in FRTL-5 thyroid cells (submitted). Further- 
more, adenosine has been reported to modulate 
permissively a histamine-receptor-linked phos- 
pholipase C system in the guinea-pig cerebral cor- 
tex [ 131. Thus, the permissive action of adenosine 
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receptor agonists may be a general signal transduc- [3] Gilman, A.G. (1987) Annu. Rev. Biochem. 56, 615-649. 
tion mechanism rather than a tissue-specific or [4] Okajima, F., Sho, K. and Kondo, Y. (1988) 
al-receptor-specific form. An IAP substrate G- 
protein plays a key role in the permissive actions. 
On the other hand, it is not clear whether the same 
G-protein mediates adenosine receptor-linked 
adenylate cyclase inhibition (fig.4). This is a novel 
mechanism by which an IAP substrate G-protein 
regulates receptor-linked phospholipase C activity, 
although the mechanism of action of this G- 
protein in the permissive effect also remains to be 
elucidated. 
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